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Background. Currently there are noreliable predictors ofresponse tocardiac resynchronizationtherapy (CRT)before implantation.
We compared pre-CRT left ventricular (LV) dyssynchrony by tissue Doppler imaging (TDI) and regional volumetric analysis
by 3-dimensional transthoracic echocardiography (3DTTE) in predicting response to CRT. Methods. Thirty-eight patients (79%
nonischemiccardiomyopathy)withsymptomatic heart failure who underwent CRT were enrolled. Clinicalandechocardiographic
responses were deﬁned as improvement in one NYHA class and reduction in LV end-systolic volume by ≥15% respectively.
Functional status was assessed by Minnesota Living with Heart Failure questionnaire and 6-minute walk distance. Results.I n3 3
patients, after CRT for 7.86 ± 2.27 months, there were 24 (73%) clinical and 19 (58%) echocardiographic responders. Functional
parameters, LV dimensions, volumes and synchrony by TDI and 3DTTE improved signiﬁcantly in responders. There was no
diﬀerence in the number of responders and nonresponders when cut-oﬀ values for dyssynchrony by diﬀerent measurements
validated in other trials were applied. Area under receiver-operating-characteristic curve ranged from 0.4 to 0.6. Conclusion.C R T
improves clinical and echocardiographic parameters in patients with systolic heart failure. The dyssynchrony measurements by
TDI and 3DTTE are not comparable and are unable to predict response to CRT.
1.Introduction
Cardiac resynchronization therapy (CRT) improves func-
tional capacity, quality of life, and reduces heart failure
(HF) symptoms. CRT alone without ICD was also shown
to reduce mortality in patients with severe HF [1]. Based
on large clinical trials [2, 3], the current recommendations
to select patients for CRT focus on electrical dyssynchrony,
such as prolonged QRS duration of >120 milliseconds [4].
However, 30–40% of patients with electrical dyssynchrony
do not exhibit mechanical dyssynchrony and remain as
nonresponders to CRT [5]. Several studies have been done
to ﬁnd an echocardiographic technique that could predict a
favorable response to CRT [6–10]. The goal of these studies
has been to ﬁnd a feasible, inexpensive, and reliable method
to identify potential responders to CRT before undergoing
the surgical procedure.
Mechanical dyssynchrony studied by tissue Doppler
imaging (TDI) has been shown to be a reliable predictor
of response after CRT in several studies [8, 11–13]. How-
ever, the results of the recent trials, including PROSPECT
(predictors of response to CRT), which studied 12 diﬀerent
2D transthoracic (2DTTE) echocardiographic dyssynchrony
parameters, did not ﬁnd any reliable parameters in pre-
dicting the response to CRT at 6 months [14, 15]. Three-
dimensional transthoracic echocardiography (3DTTE) [16–
20] with regional volumetric analysis is emerging as a new
techniqueandfeasible toassess dyssynchrony. Althoughreal-
time 3DTTE has been used to assess dyssynchrony, this
technique has not been compared to TDI in predicting2 Cardiology Research and Practice
the response to CRT [21]. We conducted this study to
compare dyssynchrony measurements by TDI and regional
volumetric analysis by 3DTTE and examine if these methods
are eﬃcient and reliable in predicting the long-term clinical
and echocardiographic response to CRT.
2.Methods
We conducted a single-center, prospective, nonrandomized
study comprising 38 consecutive patients who underwent
CRT at Stanford University, California, as per recommended
guidelines. All the patients signed an informed consent form
and a health insurance portability and accountability act
(HIPAA) form for the study. Patients with mechanical heart
valve(s), pacemaker dependence, and those with technically
inadequate echocardiographic images were excluded from
thestudy. Patients underwent clinicaland echocardiographic
assessment prior to CRT and after 6–12 months of CRT. The
clinical parameters included New York Heart Association
(NYHA) functional class, 6-minute walk distance (MWD)
and Minnesota Living with Heart Failure questionnairescore
(MNHFQ). These patients were implanted with Medtronic
(n = 29) (Insync Sentry, Medtronic Inc.) and St. Judes
(n = 4) pacemaker devices. After biventricular pacemaker
placement, A-V optimization was done by Ritter’s method
to achieve maximal end-diastolic ﬁlling duration, followed
by post-CRT imaging within 24 hours of implantation.
Clinical response was deﬁned as an improvement in NYHA
functionalclassbyoneclass,andechocardiographicresponse
was deﬁned as a reduction in LV end-systolic volume
(LVESV) of ≥15% after 6–12 months of CRT.
2.1. Transthoracic 2D Echocardiography. AP h i l i p sS o n o s
5500, M2428A 2D Ultrasound system with an S3 trans-
ducer was used to obtain LV end-systolic and end-diastolic
dimensions.Apical4-chamberviewwasobtainedtocalculate
LVESV and LV end-diastolic volume (LVEDV) to give
a LVEF by Simpson’s method. Mitral regurgitation was
semiquantitatively assessed by color Doppler across mitral
valve and graded as none (0) trace/mild (1), moderate
(2), moderately severe (3), and severe (4), respectively
[22].
2.2. Tissue Doppler Imaging. Dyssynchrony index by pulse-
wave TDI was measured as SD of the time from beginning of
QRS to the peak systolic velocity in 12 LV segments, 6 basal
and 6 mid segments of inferolateral, inferoseptal, anterior,
posterior, anteroseptal, and lateral walls with both CRT-
on and CRT-oﬀ modes. TDI parameter was measured in 3
separate heart beats and averagedforeach segment. ThenSD
for the 12 segments was calculated to derive a dyssynchrony
index as 2 SD from the mean. An index of >32ms from the
mean was considered as signiﬁcant dyssynchrony [13]. We
also calculated the diﬀerence in time to peak systolic velocity
between the fastest (Tf) and slowest (Ts) of 6 basal LV
segments (Tf-Ts) [12] and calculated septal-lateral delay. A
score of ≥65ms was considered as signiﬁcant dyssynchrony
[11].
2.3. Transthoracic 3D Echocardiography. A transthoracic full-
volume acquisition from apical view using Philips iE33
(Andover, MA, USA) with an X3-1 matrix array transducer
was performed with CRT-on and oﬀ modes. With 2 per-
pendicular planes through the LV, a 3-D model of the LV
was obtained, and it was subdivided into 17 volumetric
segments. Sequence analysis generated the time-volume
curves showing the time to the point of minimal systolic
volume (Tmsv) for each segment. Q-lab program was run to
derive the dyssynchrony index as SD of Tmsv of 12 (6 basal
and 6mid)and 16(6basal, 6mid, and4apical)LV segments.
I ta l s op r o v i d e dt h eS Do fT m s vo ft h e1 2a n d1 6s e g m e n t sa s
a percentage of the R-R interval.
3.Statistics
Continuous variables are presented as mean ± SD, and
dichotomousdataarepresentedasnumbersandpercentages.
Theclinicalandechocardiographicparametersinresponders
and nonresponders at baseline, immediately after CRT and
at 6–12 months after CRT were compared using Student’s
paired and unpaired t-tests, respectively. Categorical vari-
ables were compared with Chi-square test, and comparisons
between the clinical and echocardiographic endpoints with
diﬀerent dyssynchrony parameters were done using analysis
of variance (ANOVA). Receiver-operating characteristics
curves (ROC) were generated, and the area under the curve
represented the ability of the parameter to predict clinical or
echocardiographic response. Correlations between diﬀerent
dyssynchrony measurement techniques were examined by
Pearson correlation test. A P-value of ≤.05 was considered
statistically signiﬁcant.
4.Results
Of the 38 patients who underwent CRT, 2 patients had
failed biventricular pacing, and 3 patients did not return for
followup. After a median followup period of 7 months (7.86
± 2.27 months) in 33 patients, symptoms improved in 24
(73%) patients, unchanged in 7 (21%) patients, worsened
in one patient after CRT requiring cardiac transplantation,
and one died and these were included as nonresponders
(n = 9). Of the 24 clinical responders, 18 (55%) were also
echocardiographic responders, 5 were clinical responders
but not echocardiographic responders, and 1 patient had
clinical evaluation but did not get followup echocardiogram.
Onepatienthadechocardiographic response withoutclinical
response.
The baseline characteristics and echocardiographic mea-
surements pre-CRT and 6-12 months after CRT are shown
in Table 1.T h e r ew a sn os i g n i ﬁ c a n td i ﬀerence in clinical
response in males or females and in patients with nonis-
chemic and ischemic CM (77% versus 57%, P = NS). There
was a trend towards higher echocardiographic response in
nonischemic CM than in ischemic CM (68% versus 29%,
P = .06). Both clinical and echocardiographic responders
had longer 6-MWD as compared to nonresponders before
CRT, and it remained signiﬁcant after long-term CRTCardiology Research and Practice 3
Table 1: Baseline characteristics and echocardiographic parameters pre-CRT and after long-term CRT.
Characteristic Baseline After CRT (6 m) P-value
Age (years) 59.9 ± 12.5
Gender: males 67%
Etiology: dilated cardiomyopathy 79%
QRS duration (ms) 161.2 ± 16.9
Clinical parameters:
NYHA class (1/2/3/4) 0/7/23/3 9/17/5/2 <.0005
MNLWHF score 49.7 ± 22.4 30.4 ± 22.9 <.0005
6-minute walk distance (meters) 428 ± 69 482 ± 91 <.0005
Echocardiographic parameters:
LV end-diastolic volume (mL) 245.3 ± 128.5 192.5 ± 101.3 .006
LV end-systolic volume (mL) 188.9 ± 109.1 125.8 ± 80.3 .0002
LV ejection fraction (%) 25 ± 63 8 ± 11 .0001
LV end-diastolic diameter (cm) 6.9 ± 1.5 6.3 ± 1.5 .004
LV end-systolic diameter (cm) 6.0 ± 1.5 5.1 ± 1.6 .0008
LV fractional shortening (%) 13.3 ± 0.5 19 ± 0.9 .006
Mitral regurgitation 1.67 ± 1.1 1.32 ± 0.8 .03
TDI: SD of Tf-Ts in 12 segments (ms) 44.2 ± 14.1 34.1 ± 14.4 .0008
TDI: SD of Tf-Ts in 6 basal segments (ms) 106.3 ± 41.7 76.5 ± 35.8 .0001
TDI: SD of septal-to-lateral delay (ms) 58.1 ± 37.1 61.2 ± 36.8 .32
3D: SD of Tmsv in 6 basal segments (ms) 84.6 ± 56.4 53.9 ± 41.3 .01
3D: SD of Tmsv in 12 segments (ms) 46.3 ± 31.1 24.4 ± 20.5 .002
3D: SD of Tmsv in 16 segments (ms) 58.1 ± 35.2 35 ± 28.8 .04
3D: SD of Tmsv in 12 segments as % of R-R interval 5.8 ± 4.2% 3.1 ± 2.9% .0004
3D: SD of Tmsv in 16 segments as % of R-R interval 7.0 ± 4.1% 4.3 ± 3.8% .01
CRT: cardiac resynchronization therapy, LV: left ventricle, TDI: tissue Doppler imaging, Tf-Ts: diﬀerence in time to peak systolic velocity between the fastest
and slowest LV segments, Tmsv: diﬀerence in longest and shortest time to minimal systolic volume in LV segments, NYHA: New York Heart Association,
MNHFQ: Minnesota Living with Heart Failure questionnaire, SD: standard deviation.
(Table 1). The pre-CRT HF medications, such as beta-
blockers, ACEI/ARB, diuretics, and aldosterone receptor
antagonists remained the same after CRT without any
signiﬁcant change in their doses.
LV pacing lead was placed in posterior or postero-lateral
position (n = 24), antero-lateral position (n = 3) patients,
middle-cardiac-vein (n = 4) patients, and epicardially
placed in 2 patients. There was no diﬀerence in the lead
position in the clinical or echocardiographic responders and
nonresponders.
4.1. Immediate Response to CRT. After initiation of CRT and
AV optimization, there was no change in clinical symptoms,
but there was a signiﬁcant reduction in LV dyssynchrony
indices measured by TDI (44.2 ± 14.1 versus 33.5 ± 13.5,
P<. 05 in 12 LV segments) and 3DTTE (46.2 ± 31.0 versus
28.3 ± 19.0, P<. 05 in 12 LV segments). Analysis of the
SD of Tmsv as a function of the R-R interval in 12 segments
(5.8 ± 4.2% versus 4.5 ± 3.7%, P = NS) and 16 segments
(7.0 ± 4.1% versus 5.6 ± 4.2%, P = NS) by 3DTTE did not
show signiﬁcant improvement. The immediate reduction in
dyssynchrony score by TDI and 3DTTE did not correlate
with the clinical or echocardiographic response at 6–12
months.
4.2. Predictors of Clinical Response. After CRT of 7.86 ± 2.27
months, 24 (73%) were clinical responders with improve-
ment in1 NYHAfunctional class. In thesepatients, therewas
a signiﬁcant improvement in 6-MWD (Δ71m versus Δ22 m,
P<. 05) and in MNHFQ score (Δ22 versus Δ12, P<. 05) as
compared to nonresponders.
Clinical responders were identiﬁed with 75% sensitivity
and 38% speciﬁcity (ROC = 0.69) with pre-CRT QRS
duration of 150ms. Dyssynchrony score of 32ms with
TDI identiﬁed responders with a sensitivity of 75% and a
speciﬁcity of 12%. The clinical response was not signiﬁcantly
diﬀerent in those who met these cut-oﬀ values as compared
to those who did not (Table 2). Echocardiographic improve-
ment in LVESV >15% identiﬁed clinical responders (ROC =
0.88, P<. 003)with 84%sensitivity and 86%speciﬁcity.Pre-
CRT LVESV did not predict clinical response. There was no
signiﬁcant diﬀerencein LV dyssynchrony delta change values
in clinical responders and nonresponders (Table 2).
4.3. Predictors of Echocardiographic Response. After long-
term CRT, the average LVESV decreased by 27.5 ± 21.9%.
There were 19 (59%) echocardiographic responders with
reduction in LVESV of ≥15%, which correlated with
reduction in LV end-diastolic diameter (r = 0.6, P<. 05;4 Cardiology Research and Practice
Table 2: Diﬀerence in left ventricular function and dyssynchrony parameters in clinical responders versus nonresponders after long-term
CRT.
Variable Clinical responders (n = 24) Clinical nonresponders (n = 9) P-value
Delta change 6-months after CRT Delta change 6-months after CRT
LV end-diastolic volume (mL) 65 ± 59 12 ± 15 .03
LV end-systolic volume (mL) 74 ± 59 9 ± 10 .008
LV ejection fraction (%) 15 ± 83 ± 4 .001
LV end-diastolic diameter (cm) 0.5 ± 0.1 0.3 ± 0.6 .6
LV fractional shortening (%) 0.05 ± 0.1 0.05 ± 0.11 .9
TDI: Tf-Ts 6 basal segments (ms) 34 ± 34 18 ± 18 .24
TDI: Tf-Ts 12 segments (ms) 13 ± 12 13 ± 8. 9 6
TDI: septal-to-lateral delay (ms) 28 ± 26 54 ± 10 .07
3D: SD of Tmsv in 6 basal segments (ms) 51 ± 33 60 ± 81 .70
3D: SD of Tmsv in 12 segments (ms) 16 ± 13 28 ± 30 .16
3D: SD of Tmsv in 16 segments (ms) 34 ± 35 44 ± 35 .48
3D: SD of Tmsv in 12 segments as % of R-R interval 3.3 ± 2.9% 4.0 ± 4.3% .60
3D: SD of Tmsv in 16 segments as % of R-R interval 4.4 ± 4.0% 3.5 ± 5.4% .59
CRT: cardiac resynchronization therapy, LV: left ventricle, TDI: tissue Doppler imaging, Tf-Ts: diﬀerence in time to peak systolic velocity between the fastest
and slowest LV segments, Tmsv: diﬀerence in longest and shortest time to minimal systolic volume in LV segments, SD: standard Deviation.
ROC = 0.56 for LV diameter of 5 millimeters). As compared
to theechocardiographic nonresponders, the responders had
signiﬁcant improvement in LV volumes, ejection fraction,
and LV dimensions. Overall, there was signiﬁcant improve-
ment in dyssynchrony values after CRT (Table 1); however,
the absolute delta changes in LV dyssynchrony values were
similar in echocardiographic responders and nonrespon-
ders(Table 3). Echocardiographic responderswere identiﬁed
with 77% sensitivity and 34% speciﬁcity (ROC = 0.67)
with pre-CRT QRS duration of 150ms. Dyssynchrony score
of 32ms with TDI identiﬁed responders with a sensitivity
of 73% and a speciﬁcity of 15%. The echocardiographic
response was not signiﬁcantly diﬀerentin thosewho met this
cut-oﬀ value of dyssynchrony as compared to those who did
not (Table 4).
4.4. Correlation between Dyssynchrony Indices by QRS dura-
tion, TDI, and 3D Volumetric Analysis. The pre-CRT QRS
duration had signiﬁcant correlation with dyssynchrony score
by TDI in 12 segments (r = 0.7, P = .009) and with Tf-Ts
in 6 basal segments (r = 0.6, P = .01). The dyssynchrony
score by TDI in 12 LV segments correlated with septal-
lateral delay (r = 0.6, P<. 05) and with Tf-Ts in 6
basal segments (r = 0.8, P<. 05). Similarly, dyssynchrony
scores by 3D volumetric analysis in 12 LV segments and 16
segments expressed as percentage of cardiac cycle correlated
signiﬁcantly (r = 0.8, P<. 05). However, there was no
correlation between TDI and 3D measurements (Table 5).
5.Discussion
In our study, we noted improved LV systolic function and
reduced LV volumes and dimensions after long-term CRT
signifying reverseremodelingofLV. Therewasalsoreduction
in LV dyssynchrony scores by several TDI and 3DTTE
measurements after CRT; however, these did not help to
identify responders before the procedure. The dyssynchrony
scores by these techniques did not correlate with each
other.
As seen in prior studies, there were more clinical
responders than echocardiographic responders to CRT [6].
Subjective improvement in NYHA functional class was asso-
ciated with objective improvement in 6-MWD as reported
before [1–3, 23]. The remaining patients with only clinical
response without a reduction in LVESV probably had a
placebo eﬀect after pacemaker implantation or had some
beneﬁcial eﬀect on LV mechanics without evident signiﬁcant
reverse remodeling. CRT was implanted in 5 (13%) patients
with NYHA functional class II symptoms, although their
quality of life was signiﬁcantly aﬀected compared to their
baseline and could be classiﬁed as IIIa, and opted to undergo
CRT. The recent MADIT-CRT trial conducted in patients
with mild heart failure symptoms showed a beneﬁcial eﬀect
of CRT [24]. As reported in MADIT-CRT and in CARE-
HF trials [25], our study also showed similar clinical and
echocardiographic response in ischemic and nonischemic
etiology of cardiomyopathy [26].
Echocardiographic responders showed LV reverse
remodeling without signiﬁcant change in dyssynchrony
as compared to nonresponders. Reverse remodeling of
LV with improvement in LV volumes, dimensions, and
LVEF with CRT has been reproduced in several studies
[3, 8, 24, 27]. LVESV is a reliable indicator of LV reverse
remodeling, and it correlated with the clinical improvement
in symptoms. However, pre-CRT LVESV did not identify
CRT responders before implantation. The additional
information on dyssynchrony by diﬀerent methods did
not seem to identify responders or improve the selection
criteria. It is intuitive that correction of dyssynchrony is
probably necessary to facilitate reverse remodeling and
clinical improvement [28], but the available methods toCardiology Research and Practice 5
Table 3: Diﬀerence in left ventricular function and dyssynchrony parameters in echocardiographic responders versus nonresponders after
long-term CRT.
Variable
Echocardiographic responders
(n = 19)
Echocardiographic nonresponders
(n = 13) P-value
Delta change 6-months after CRT Delta change 6-months after CRT
LV end-diastolic volume (mL) 71 ± 60 18 ± 26 .01
LV end-systolic volume (mL) 82 ± 58 8 ± 7 .0009
LV ejection fraction (%) 15 ± 96 ± 7. 0 1
LV end-diastolic diameter (cm) 0.7 ± 0.8 0.03 ± 0.6 .03
LV fractional shortening (%) 0.06 ± 0.1 0.03 ± 0.07 .3
TDI: Tf-Ts 6 basal segments (ms) 37 ± 34 15 ± 17 .08
TDI: Tf-Ts 12 segments (ms) 14 ± 12 10 ± 8. 3 6
TDI: septal-to-lateral delay (ms) 31 ± 27 41 ± 24 .43
3D: SD of Tmsv in 6 basal segments (ms) 45 ± 35 68 ± 68 .30
3D: SD of Tmsv in 12 segments (ms) 14 ± 13 27 ± 25 .13
3D: SD of Tmsv in 16 segments (ms) 35 ± 37 42 ± 33 .61
3D: SD of Tmsv in 12 segments as % of R-R interval 3.5 ± 3.0% 3.5 ± 4.0% .97
3D: SD of Tmsv in 16 segments as % of R-R interval 3.9 ± 4.6% 4.7 ± 4.0% .61
∗P<. 05, CRT: cardiac resynchronization therapy, LV: left ventricle, TDI: tissue Doppler imaging, Tf-Ts: diﬀerence in time to peak systolic velocity between
the fastest and slowest LV segments,Tmsv: diﬀerence in longest and shortest time to minimal systolic volume in LV segments, SD: standard Deviation.
Table 4:AssessmentofQRS durationand echocardiographic dyssynchrony parameters validated inother trials to predict long-term clinical
and echocardiographic response.
Pre-CRT dyssynchrony
parameters
Total
(n = 33)
Clinical
responders
(n = 24)
P-value
Echocardiographic
responders
(n = 19)
P-value
QRS (ms)
<150 9 6 0.6 6 0.7
≥150 24 18 13
TDI septal-lateral delay (ms)
<65 20 17 0.1 13 0.2
≥65 13 8 6
TDI (Tf-Ts) 12 LV segments (ms)
<32 6 5 0.5 4 0.6
≥32 27 19 15
TDI (Tf-Ts) 6 basal LV segments (ms)
<83 10 7 0.8 7 0.5
≥83 23 17 12
CRT: cardiac resynchronization therapy, LV: left ventricle, TDI: tissue Doppler imaging, Tf-Ts: diﬀerence in time to peak systolic velocity between the fastest
and slowest LV segments.
assess dyssynchrony are inadequate and time consuming.
Until we have reliable techniques, QRS duration remains
t h es i m p l ec h o i c et os e l e c tp a t i e n t sf o rC R T .A l t h o u g ht h e
cut-oﬀ value for selection of patients for CRT was 130ms,
ac u t - o ﬀ value of 150ms was used to identify responders as
patients with wider QRS had better response to CRT in a
large, randomized trial such as CARE-HF, and most of the
patients enrolled had QRS 150ms [1].
In our study, on applying the cut-oﬀ values based on
prior trials, the responders did not show more dyssynchrony
as compared to nonresponders prior to CRT [8, 9, 11–
13, 29]. The PROSPECT trial evaluated seven TDI-based
dyssynchrony scores and reported variable predictive values
andconcludedthatnosingleechocardiographicmeasurewas
reliable in identifying responders. Interestingly, this study
also highlighted the limitations of obtaining reliable images
doneatdiﬀerentcenters[14],which is currentlya problemin
low-volume practices, not involved in research. Despite our
study being conducted in a single university setting with a
high volume of CRT insertions and echocardiographers with6 Cardiology Research and Practice
Table 5:Correlationbetween leftventriculardyssynchronyindicesbyQRSduration,TDI,and3Dvolumetricanalysisinpatientsundergoing
CRT.
Pearson’s
correlation
coeﬃcient
QRS
dura-
tion
(ms)
TDI:
septal-to-
lateral delay
TDI: Tf-Ts
6 basal
segments
(ms)
TDI: Tf-Ts
12 basal
segments
(ms)
3D: SD of Tmsv
in 12 segments
as % of R-R
interval
3D: SD of Tmsv
in 16 segments
as % of R-R
interval
QRS duration (ms) Cor. coeﬀ. 1 0.3 0.6 0.7 0.05 0.1
P-value 0.07 <0.05 <0.05 0.8 0.5
TDI: Septal-to-lateral delay Cor. coeﬀ.0 . 3 1 0.6 0.6 0.06 0.03
P-value 0.07 <0.05 <0.05 0.7 0.8
TDI: Tf-Ts 6 basal segments
(ms)
Cor. coeﬀ.0 . 6 0 . 6 1 0.8 0.05 0.2
P-value <0.05 <0.05 <0.05 0.7 0.2
TDI: Tf-Ts 12 basal segments
(ms)
Cor. coeﬀ. 0.7 0.6 0.8 1 0.03 0.1
P-value <0.05 <0.05 <0.05 0.8 0.5
3D: SD of Tmsv in 12 segments
as % of R-R interval
Cor. coeﬀ. 0.05 0.06 0.05 0.03 1 0.8
P-value 0.8 0.7 0.7 0.8 <0.05
3D: SD of Tmsv in 16 segments
as % of R-R interval
Cor. coeﬀ. 0.1 0.03 0.2 0.1 0.8 1
P-value 0.5 0.8 0.2 0.5 <0.05
CRT: cardiac resynchronization therapy, TDI: tissue Doppler imaging, Tf-Ts: diﬀerence in time to peak systolic velocity between the fastest and slowest LV
segments,Tmsv:diﬀerence inlongestand shortesttimetominimalsystolicvolumeinLVsegments,SD: standarddeviation, Cor. Coeﬀ.:correlationcoeﬃcient.
an expertise in obtaining and interpreting TDI and 3D echo
images, similar limitations were encountered.
A recent study by Marsan et al. showed good correlation
in dyssynchrony scores by regional volumetric analysis by
3DTTE and gated myocardial perfusion single-photon emis-
sion computed tomography [17]. Kleijn et al. compared TDI
and real-time 3DTTE and reported nonagreement between
thetwotechniqueswhencurrentdyssynchrony cut-oﬀvalues
were applied [21]. In our study, except for the QRS and TDI
values,the TDIand 3DTTE dyssynchrony measurements did
not correlate signiﬁcantly, consistent with our observation in
previous study [19]. The likely reason may be that TDI and
3DTTE measure diﬀerent events like time-to-peak systolic
velocity by TDI and time-to-minimal-systolic volume by
3DTTE, and these timings may not correlate, especially in
dyssynchronous LV segments.
Early improvement in LV dyssynchrony has been shown
to be predictive of long-term favorable response to CRT in
prior studies [26, 27, 30] unlike our study. But the goal is
to identify the responders before a patient undergoes CRT
procedure. Soliman et al. showed that 3DTTE dyssynchrony
scores before CRT were useful in identifying long-term
echocardiographic responders to CRT [20]. Multicenter
studies are needed to see if this technique can reproduce
similar results.
6.Limitations
The main limitation of our study is the small sample size,
although studies with a larger sample such as PROSPECT
yielded similar results. There are several other dyssynchrony
parameters used in various studies, but we did not assess all
of them. The median followup was limited to 7 months as
the results of the study did not contributeto clinical decision
making and were time consuming.
7.Conclusion
CRT leads to improved functional status, LV reverse remod-
eling, and improved synchrony between LV segments in
patients with systolic HF. The dyssynchrony measurements
by TDI and 3DTTE volumetric analysis do not correlate well
with each other, and do not appear to be signiﬁcantly related
to measure of outcomes.
Acknowledgments
The authors would like to thank the staﬀ in the echocar-
diography laboratory (Allan Paloma, Judy Chow and,
Josephine Puryear) and the electrophysiology laboratory
(Marcia Glassford, Kelly Green, and Linda Ottobani) for
their invaluable support in conducting this study.
References
[ 1 ] J .G .F .C l e l a n d ,J .C .D a u b e r t ,E .E r d m a n ne ta l . ,“ T h ee ﬀect of
cardiacresynchronizationonmorbidityandmortalityinheart
failure,” New England Journal of Medicine, vol. 352, no. 15, pp.
1539–1549, 2005.
[2] S. Cazeau, C. Leclercq, T. Lavergne et al., “Eﬀects of mul-
tisite biventricular pacing in patients with heart failure and
intraventricular conduction delay,” New England Journal of
Medicine, vol. 344, no. 12, pp. 873–880, 2001.
[ 3 ]W .T .A b r a h a m ,W .G .F i s h e r ,A .L .S m i t he ta l . ,“ C a r d i a c
resynchronization in chronic heart failure,” New England
Journal of Medicine, vol. 346, no. 24, pp. 1845–1853, 2002.
[4] G. Gregoratos, J. Abrams, A. E. Epstein et al., “ACC/AHA/
NASPE 2002 guideline update for implantation of cardiac
pacemakers and antiarrhythmia devices: summary article.
A report of the American College of Cardiology/Ameri-
can Heart Association Task Force on Practice Guide-
lines (ACC/AHA/NASPE Committee to Update the 1998Cardiology Research and Practice 7
Pacemaker Guidelines),” Journal of Cardiovascular Electrophys-
iology, vol. 13, no. 11, pp. 1183–1199, 2002.
[5] G. B. Bleeker, M. J. Schalij, S. G. Molhoek et al., “Relationship
between QRS duration and left ventricular dyssynchrony in
patients with end-stage heart failure,” Journal of Cardiovascu-
lar Electrophysiology, vol. 15, no. 5, pp. 544–549, 2004.
[ 6 ]G .B .B l e e k e r ,J .J .B a x ,J .W .H .F u n ge ta l . ,“ C l i n i c a lv e r s u s
echocardiographic parameters to assess response to cardiac
resynchronization therapy,” American Journal of Cardiology,
vol. 97, no. 2, pp. 260–263, 2006.
[ 7 ] C .M .Y u ,W .T .A b r a h a m ,J .B a xe ta l . ,“ P r e d i c t o r so fr e s p o n s e
to cardiac resynchronization therapy (PROSPECT)—study
design,” American Heart Journal, vol. 149, no. 4, pp. 600–605,
2005.
[8] P. Sogaard, H. Egeblad, W. Y. Kim et al., “Tissue Doppler
imaging predicts improved systolic performance and reversed
left ventricular remodeling during long-term cardiac resyn-
chronization therapy,” Journal of the American College of
Cardiology, vol. 40, no. 4, pp. 723–730, 2002.
[9] M. V. Pitzalis, M. Iacoviello, R. Romito et al., “Cardiac
resynchronizationtherapy tailoredby echocardiographic eval-
uation of ventricular asynchrony,” Journal of the American
College of Cardiology, vol. 40, no. 9, pp. 1615–1622, 2002.
[10] M. V. Pitzalis, M. Iacoviello, R. Romito et al., “Ventricular
asynchrony predicts a better outcome in patients with chronic
heart failure receiving cardiac resynchronization therapy,”
Journal of the American College of Cardiology, vol. 45, no. 1,
pp. 65–69, 2005.
[11] J. J. Bax, G. B. Bleeker, T. H. Marwick et al., “Left ventricular
dyssynchrony predicts response and prognosis after cardiac
resynchronization therapy,” Journal of the American College of
Cardiology, vol. 44, no. 9, pp. 1834–1840, 2004.
[12] D. Notabartolo, J. D. Merlino, A. L. Smith et al., “Usefulness
of the peak velocity diﬀerence by tissue Doppler imaging
technique as an eﬀective predictor of response to cardiac
resynchronization therapy,” American Journal of Cardiology,
vol. 94, no. 6, pp. 817–820, 2004.
[13] C. M. Yu, W. H. Fung, H. Lin, Q. Zhang, J. E. Sanderson, and
C. P. Lau, “Predictors of left ventricular reverse remodeling
after cardiac resynchronization therapy for heart failure
secondary to idiopathic dilated or ischemic cardiomyopathy,”
American Journal of Cardiology, vol. 91, no. 6, pp. 684–688,
2003.
[14] E. S. Chung, A. R. Leon, L. Tavazzi et al., “Results of the
predictors of response to crt (prospect) trial,” Circulation,v o l .
117, no. 20, pp. 2608–2616, 2008.
[15] O. I. I. Soliman, D. A. M. J. Theuns, M. L. Geleijnse et al.,
“Spectral pulsed-wavetissueDopplerimaginglateral-to-septal
delay fails to predict clinical or echocardiographic outcome
after cardiac resynchronization therapy,” Europace,v o l .9 ,n o .
2, pp. 113–118, 2007.
[ 1 6 ]Q .Z h a n g ,C .M .Y u ,J .W .H .F u n ge ta l . ,“ A s s e s s m e n to ft h e
eﬀect ofcardiacresynchronization therapy onintraventricular
mechanical synchronicity by regional volumetric changes,”
American Journal of Cardiology, vol. 95, no. 1, pp. 126–129,
2005.
[17] N. A. Marsan, M. M. Henneman, J. Chen et al., “Real-time
three-dimensional echocardiography as a novel approach to
quantify left ventricular dyssynchrony: a comparison study
with phase analysis of gated myocardial perfusion single pho-
ton emission computed tomography,” Journal of the American
Society of Echocardiography, vol. 21, no. 7, pp. 801–807, 2008.
[18] S. Kapetanakis, M. T. Kearney, A. Siva, N. Gall, M. Cooklin,
and M. J. Monaghan, “Real-time three-dimensional echocar-
diography: anoveltechnique toquantifygloballeftventricular
mechanical dyssynchrony,” Circulation, vol. 112, no. 7, pp.
992–1000, 2005.
[19] S. S.Kuppahally, M. B.Fowler, R. Vageloset al.,“Worseningof
left ventricular end-systolic volume and mitral regurgitation
w i t h o u ti n c r e a s ei nl e f tv e n t r i c u l a rd y s s y n c h r o n yo na c u t e
interruption of cardiac resynchronization therapy,” Echocar-
diography, vol. 26, no. 7, pp. 759–765, 2009.
[20] O. I. I. Soliman, M. L. Geleijnse, D. A. M. J. Theuns
et al., “Usefulness of left ventricular systolic dyssynchrony
by real-time three-dimensional echocardiography to predict
long-term response to cardiac resynchronization therapy,”
American Journal of Cardiology, vol. 103, no. 11, pp. 1586–
1591, 2009.
[21] S. A. Kleijn, J. van Dijk, C. C. de Cock, C. P. Allaart, A. C.
van Rossum, and O. Kamp, “Assessment of intraventricular
mechanical dyssynchrony and prediction of response to
cardiacresynchronizationtherapy: comparisonbetween tissue
Doppler imaging and real-time three-dimensional echocar-
diography,” Journal of the American Society of Echocardiogra-
phy, vol. 22, no. 9, pp. 1047–1054, 2009.
[22] J. D. Thomas, “How leaky is that mitral valve? Simpliﬁed
Doppler methods to measure regurgitant oriﬁce area,” Circu-
lation, vol. 95, no. 3, pp. 548–550, 1997.
[23] J.B.Young, W.T. Abraham,A.L.Smithet al.,“Combined car-
diac resynchronization and implantable cardioversion deﬁb-
rillation in advanced chronic heart failure: the MIRACLE ICD
trial,”Journal of theAmerican MedicalAssociation,vol.289,no.
20, pp. 2685–2694, 2003.
[24] A. J. Moss, W. J. Hall, D. S. Cannom et al., “Cardiac-
resynchronization therapy for the prevention of heart-failure
events,” New England Journal of Medicine, vol. 361, no. 14, pp.
1329–1338, 2009.
[25] G. Wikstrom,C. Blomstr¨ om- L u nd q vist ,B .A nd r e ne tal. ,“T he
eﬀects ofaetiologyonoutcomeinpatientstreated withcardiac
resynchronization therapy in the CARE-HF trial,” European
Heart Journal, vol. 30, no. 7, pp. 782–788, 2009.
[26] N. A. Marsan, G. B. Bleeker, R. J. van Bommel et al.,
“Comparison of time course of response to cardiac resynchro-
nization therapy in patients with ischemicversus nonischemic
cardiomyopathy,”American Journal of Cardiology,vol.103,no.
5, pp. 690–694, 2009.
[ 2 7 ]A .J .B a n k ,C .L .K a u f m a n ,A .S .K e l l ye ta l . ,“ R e s u l t so f
the prospective Minnesota study of ECHO/TDI in cardiac
resynchronizationtherapy (PROMISE-CRT) study,” Journal of
Cardiac Failure, vol. 15, no. 5, pp. 401–409, 2009.
[ 2 8 ]G .B .B l e e k e r ,S .A .M o l l e m a ,E .R .H o l m a ne ta l . ,“ L e f t
ventricular resynchronization is mandatory for response to
cardiac resynchronization therapy: analysis in patients with
echocardiographic evidence of left ventricular dyssynchrony
at baseline,”Circulation, vol.116,no.13,pp. 1440–1448,2007.
[29] C.-M. Yu, H. Lin, Q. Zhang, and J. E. Sanderson, “High
prevalence of left ventricular systolic and diastolic asynchrony
in patients with congestive heart failure and normal QRS
duration,” Heart, vol. 89, no. 1, pp. 54–60, 2003.
[30] R. Abdelhadi, E. Adelstein, A. Voigt, J. Gorcsan, and S. Saba,
“Measures of left ventriculardyssynchrony andthecorrelation
to clinical and echocardiographic response after cardiac
resynchronization therapy,” American Journal of Cardiology,
vol. 102, no. 5, pp. 598–601, 2008.